AAIC 2025 Abstract
Use of Potentially Inappropriate Medications for People with Diabetes as a Confounding Factor in Alzheimer's Diagnosis: An Analysis Using the ADNI Database
By Taiane Santos Garcia, Sheyla Velasques Paladini, João Pedro Ferrari-Souza, Show 2 more authorsAgnes Nogueira Gossenheimer
Study in peoplePopulations
Abstract
Background: The Alzheimer's Disease Neuroimaging Initiative (ADNI) aims to improve Alzheimer's disease (AD) clinical trials. Patients with diabetes often use potentially inappropriate medications (PIMs), which can impact cognitive function, influence neurodegenerative biomarkers, and confound Alzheimer's diagnosis.
